Home › Trial NCT05594290
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery
- Trial IDNCT05594290
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorGruppo Oncologico del Nord-Ovest
- Enrollment36
- Start date2022-12-07
- ConditionsMerkel Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.